BF Biosciences gains DRAP's approval for brownfield expansion

MG News | September 09, 2024 at 11:49 AM GMT+05:00

0:00

September 09, 2024 (MLN): BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ), has secured approval from the Drug Regulatory Authority of Pakistan (DRAP) for its brownfield expansion (Line II).

This expansion includes a pre-filled syringes line, a liquid and lyophilized line, and a product development section.

The commercial production from the pre-filled syringes line has commenced, whereas the liquid & lyophilized line is under internal validation and will start commercial production in the second quarter of FY 2024-25.

Additionally, BF Biosciences Limited has launched Sematide (Semaglutide) in a pre-filled syringe.

Sematide is the first Glucagon-Like Peptide 1 (GLP1) receptor agonist approved for local manufacture in Pakistan, offering a convenient solution for diabetes management.

The pre-filled syringe eliminates dosing errors and is easy to use by the patients.

Sematide is being manufactured at the new state-of-the-art European prefilled syringes line of BF Biosciences Limited.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	145,251.75 254.63M	-0.27% -395.39
ALLSHR	89,712.67 488.11M	-0.22% -193.69
KSE30	44,560.83 116.00M	-0.44% -197.20
KMI30	206,711.05 123.20M	-0.60% -1251.39
KMIALLSHR	59,937.94 267.01M	-0.45% -270.75
BKTi	39,934.01 19.08M	-0.40% -160.24
OGTi	30,644.85 40.41M	-0.12% -38.21

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	116,975.00	118,405.00 116,880.00	-1190.00 -1.01%
BRENT CRUDE	67.03	67.06 65.80	0.60 0.90%
RICHARDS BAY COAL MONTHLY	96.50	0.00 0.00	2.20 2.33%
ROTTERDAM COAL MONTHLY	104.50	104.50 104.50	-0.30 -0.29%
USD RBD PALM OLEIN	998.50	998.50 998.50	0.00 0.00%
CRUDE OIL - WTI	64.40	64.45 63.19	0.52 0.81%
SUGAR #11 WORLD	16.19	16.20 16.02	0.18 1.12%